Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Peptidego Biotech is a specialized biotechnology company focused on the research, development, and manufacturing of high-quality peptides for the pharmaceutical and cosmetic industries. Based in Hangzhou, China, the company offers a comprehensive suite of services including custom peptide synthesis, structural modification, and large-scale production under strict quality control standards. Peptidego supports drug discovery efforts through the provision of modified peptides, isotope-labeled peptides, and peptide-drug conjugates (PDCs). Their expertise extends to the development of bioactive peptides for skincare and therapeutic applications, serving a global clientele of research institutions and biotech firms. The company leverages advanced synthesis technologies to provide cost-effective and reliable peptide solutions for complex biological research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Peptidego Biotech.